GSK vet Deb­o­rah Wa­ter­house takes CEO spot at Vi­iv; Is Sanofi pon­der­ing an Acte­lion bid?

GSK in­sid­er Deb­o­rah Wa­ter­house, cur­rent­ly an SVP run­ning the pri­ma­ry care ops of the US phar­ma di­vi­sion, has been tapped as the new CEO of Vi­iv, an am­bi­tious joint ven­ture fo­cused on HIV. A 20-year vet­er­an, Wa­ter­house is tak­ing the place of Do­minique Limet, who de­parts at the end of March. Vi­iv has been able to make sig­nif­i­cant progress in adding new prod­ucts and grow­ing sales, mak­ing it a key part of the GSK or­ga­ni­za­tion. It’s part­nered with Pfiz­er on the group.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER